Jyoti Malhotra1, Lisa E Paddock2, Yong Lin3, Sharon R Pine3, Muhammad H Habib3, Antoinette Stroup2, Sharon Manne3. 1. Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, 195, Little Albany Street, New Brunswick, NJ, USA. Jyoti.malhotra@rutgers.edu. 2. New Jersey Statewide Cancer Registry, Trenton, NJ, USA. 3. Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, 195, Little Albany Street, New Brunswick, NJ, USA.
Abstract
PURPOSE: To investigate if race impacts receipt of follow-up care in lung cancer survivors, we conducted a cross-sectional study in lung cancer survivors recruited through the New Jersey State Cancer Registry (NJSCR). METHODS: Between May 2019 and December 2019, survivors of early-stage NSCLC were identified and recruited from the NJSCR. Eligible participants were asked to complete a paper survey questionnaire and medical record release form sent to them by mail. RESULTS: Of the 112 survivors included in the analysis, 78 (70%) were non-Hispanic (NH) Whites and 34 (30%) were NH Blacks. Mean age was 67 years, 61% were female, and 92% had cancer in remission. A total of 82% of participants reported receiving a surveillance scan (CT or PET) within 1 year of completing the study survey. More NH White survivors received a scan within a year compared to NH Black survivors (89% vs 70%; p = 0.02). More NH White survivors (94%) reported that they were informed of the need for follow-up care by their provider compared to NH Blacks (71%; p = 0.002). Only 57% survivors reported receiving a treatment summary. Significant barriers to care were out-of-pocket costs (24%), non-coverage of test (12.5%), and lack of insurance (10%). CONCLUSIONS: Significant disparity was identified between NH Blacks and NH Whites in receipt of surveillance scans, as well as in receiving information about need for follow-up care. Low income, lack of insurance, and other financial concerns were identified as significant barriers to follow-up care. IMPLICATIONS FOR CANCER SURVIVORS: Future interventions to increase survivorship care should target specific unmet needs identified in each survivor population.
PURPOSE: To investigate if race impacts receipt of follow-up care in lung cancer survivors, we conducted a cross-sectional study in lung cancer survivors recruited through the New Jersey State Cancer Registry (NJSCR). METHODS: Between May 2019 and December 2019, survivors of early-stage NSCLC were identified and recruited from the NJSCR. Eligible participants were asked to complete a paper survey questionnaire and medical record release form sent to them by mail. RESULTS: Of the 112 survivors included in the analysis, 78 (70%) were non-Hispanic (NH) Whites and 34 (30%) were NH Blacks. Mean age was 67 years, 61% were female, and 92% had cancer in remission. A total of 82% of participants reported receiving a surveillance scan (CT or PET) within 1 year of completing the study survey. More NH White survivors received a scan within a year compared to NH Black survivors (89% vs 70%; p = 0.02). More NH White survivors (94%) reported that they were informed of the need for follow-up care by their provider compared to NH Blacks (71%; p = 0.002). Only 57% survivors reported receiving a treatment summary. Significant barriers to care were out-of-pocket costs (24%), non-coverage of test (12.5%), and lack of insurance (10%). CONCLUSIONS: Significant disparity was identified between NH Blacks and NH Whites in receipt of surveillance scans, as well as in receiving information about need for follow-up care. Low income, lack of insurance, and other financial concerns were identified as significant barriers to follow-up care. IMPLICATIONS FOR CANCER SURVIVORS: Future interventions to increase survivorship care should target specific unmet needs identified in each survivor population.
Authors: A William Blackstock; James E Herndon; Electra D Paskett; Michael C Perry; Stephen L Graziano; Joseph J Muscato; Michael P Kosty; Wallace L Akerley; Jimmie Holland; Stewart Fleishman; Mark R Green Journal: J Natl Cancer Inst Date: 2002-02-20 Impact factor: 13.506
Authors: Charles R Mulligan; Amir D Meram; Courtney D Proctor; Hongyu Wu; Kangmin Zhu; Aizen J Marrogi Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-01 Impact factor: 4.254
Authors: Masatsugu Hamaji; Mark S Allen; Stephen D Cassivi; Claude Deschamps; Francis C Nichols; Dennis A Wigle; K Robert Shen Journal: J Thorac Cardiovasc Surg Date: 2013-03 Impact factor: 5.209
Authors: Joseph M Pepek; Junzo P Chino; Lawrence B Marks; Thomas A D'amico; David S Yoo; Mark W Onaitis; Neal E Ready; Jessica L Hubbs; Jessamy Boyd; Chris R Kelsey Journal: J Thorac Oncol Date: 2011-04 Impact factor: 15.609
Authors: Benjamin D Smith; Grace L Smith; Arti Hurria; Gabriel N Hortobagyi; Thomas A Buchholz Journal: J Clin Oncol Date: 2009-04-29 Impact factor: 44.544
Authors: Ahmedin Jemal; Michael J Thun; Lynn A G Ries; Holly L Howe; Hannah K Weir; Melissa M Center; Elizabeth Ward; Xiao-Cheng Wu; Christie Eheman; Robert Anderson; Umed A Ajani; Betsy Kohler; Brenda K Edwards Journal: J Natl Cancer Inst Date: 2008-11-25 Impact factor: 13.506